NATCO Launches Chlorantraniliprole Formulated Product NATGEN

Natco Pharma Limited (NSE: NATCOPHARM; BSE: 524816) has launched Chlorantraniliprole (CTPR) 18.5% SC under the Brand Name of NATGEN in Indian Market.

NATCO estimates the current market size of CTPR containing products in India to be over INR 2000 crores.

Source : Equity Bulls

Keywords

NatcoPharma Chlorantraniliprole NATGEN IndianMarket